Extendicare (TSE:EXE)

Extendicare (TSE:EXE) Stock Price & Analysis


EXE Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$6.32 - C$7.55
Previous CloseC$6.75
Average Volume (3M)163.64K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$174.61M
Total Debt (Recent Filing)C$372.28M
Price to Earnings (P/E)-1125.0
Next EarningsMar 02, 2023
EPS EstimateN/A
Dividend Yield0.35 (7.11%)
EPS (TTM)>-0.01
Shares Outstanding84,728,744
Standard Deviation0.08
10 Day Avg. Volume248,463
30 Day Avg. Volume163,640
Price to Book (P/B)15.44
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)7.80
P/FCF Ratio2.70
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside7.41% Upside
Rating ConsensusHold
Number of Analyst Covering2




What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was C$6.32 and its highest was C$7.55 in the past 12 months.
    What is Extendicare’s market cap?
    Currently, no data Available
    When is Extendicare’s upcoming earnings report date?
    Extendicare’s upcoming earnings report date is Mar 02, 2023 which is in 24 days.
      How were Extendicare’s earnings last quarter?
      Extendicare released its earnings results on Nov 10, 2022. The company reported -C$0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.04.
        Is Extendicare overvalued?
        According to Wall Street analysts Extendicare’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Extendicare pay dividends?
          Extendicare pays a Monthly dividend of C$0.04 which represents an annual dividend yield of 7.11%. See more information on Extendicare dividends here
            What is Extendicare’s EPS estimate?
            Extendicare’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Extendicare have?
            Extendicare has 83,938,900 shares outstanding.
              What happened to Extendicare’s price movement after its last earnings report?
              Extendicare reported an EPS of -C$0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.697%.
                Which hedge fund is a major shareholder of Extendicare?
                Currently, no hedge funds are holding shares in TSE:EXE


                Extendicare Stock Smart Score

                The Extendicare stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description


                Extendicare Inc is a long-term care facilities company. The business has five segments including Long-term care; Retirement living; Home health care; Other Canadian operations and Corporate segment. The long-term care segment represents the long-term care homes operated by the company. The Retirement Living segment operates retirement communities that provide services to private-pay residents. The Home Health Care segment provides nursing care, physical therapy, and assisting services to accommodate individuals living at home. The Other Canadian Operations segment provides consulting services to other care providers. The company generates a vast majority of its revenue from Canada.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Sienna Senior Living
                Chartwell Retirement Residences

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis